Clinical trials sponsored by Tasly Pharmaceutical Group Co., Ltd

Phase breakdown

Conditions studied

Recruiting trials led by Tasly Pharmaceutical Group Co., Ltd

• A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
  NCT07265349 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 4 locations
• Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
  NCT06058546 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations
• HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)
  NCT05632861 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 20 locations
• Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
  NCT07687186 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 60 locations
• TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy
  NCT07514065 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Tasly Pharmaceutical Group Co., Ltd recruiting for?

Tasly Pharmaceutical Group Co., Ltd is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.